Dipeptidyl aspartyl fluoromethylketones as potent caspase-3 inhibitors: SAR of the P2 amino acid
The synthesis and SAR of dipeptidyl aspartyl fluoromethylketones as caspase-3 inhibitors is reported.
References (20)
J. Cell. Biochem.
(1997)- et al.
Bioorg. Med. Chem. Lett.
(1998)et al.J. Med. Chem.
(1996)et al.Bioorg. Med. Chem. Lett.
(1998) - et al.
J. Med. Chem.
(2001) - et al.
Bioorg. Med. Chem.
(2002) - (a)Cai, S. X.; Drewe, J.; Wang, Y.; Weber, E. US Patent 6,153,591,...(b)Keana, J. F. W.; Cai, S. X.; Guastella, J.; Wu, Y.; Drewe, J. A. US Patent 6,184,210,...
- et al.
Tetrahedron Lett.
(1994) - et al.
Biochemistry
(1994) - et al.
Biochemistry
(2003) - et al.
J. Med. Chem.
(2000)Exp. Opin. Ther. Patents
(2001) - et al.
Chem. Biol.
(2000)
There are more references available in the full text version of this article.
Cited by (0)
- †
Current address: Insert Therapeutics, Inc. Pasadena, CA 91107, USA.
Copyright © 2003 Elsevier Ltd. All rights reserved.